RIV Capital Inc
RIV Capital Inc., formerly known as Canopy Rivers Inc., is a venture capital firm. The firm is a stage agnostic, with seed to sale, although it prefers to invest in series A to C rounds. It prefers to make investments in cannabis sector with focus on burgeoning marijuana companies and sectors like agriculture and food sciences, production, processing, pharmaceuticals and biotechnology, software a… Read more
RIV Capital Inc (CNPOF) - Net Assets
Latest net assets as of September 2024: $-35.84 Million USD
Based on the latest financial reports, RIV Capital Inc (CNPOF) has net assets worth $-35.84 Million USD as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($124.91 Million) and total liabilities ($160.75 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-35.84 Million |
| % of Total Assets | -28.7% |
| Annual Growth Rate | N/A |
| 5-Year Change | -198.41% |
| 10-Year Change | N/A |
| Growth Volatility | 62355.28 |
RIV Capital Inc - Net Assets Trend (2017–2023)
This chart illustrates how RIV Capital Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for RIV Capital Inc (2017–2023)
The table below shows the annual net assets of RIV Capital Inc from 2017 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $-206.22 Million | -289.46% |
| 2022-12-31 | $108.85 Million | -58.89% |
| 2021-12-31 | $264.80 Million | +7.37% |
| 2020-12-31 | $246.61 Million | +17.68% |
| 2019-12-31 | $209.56 Million | -48.66% |
| 2018-12-31 | $408.19 Million | +167242.15% |
| 2017-12-31 | $243.92K | -- |
Equity Component Analysis
This analysis shows how different components contribute to RIV Capital Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 4184517700.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $41.82 Million | 19.23% |
| Common Stock | $170.00 Million | 78.16% |
| Other Comprehensive Income | $41.82 Million | 19.23% |
| Total Equity | $217.50 Million | 100.00% |
RIV Capital Inc Competitors by Market Cap
The table below lists competitors of RIV Capital Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Viking Mines Limited
F:AVI
|
$10.23 Million |
|
Stel Holdings Limited
NSE:STEL
|
$10.23 Million |
|
Swoop Holdings Ltd
AU:SWP
|
$10.24 Million |
|
IKONISYS EO 2
F:9W8
|
$10.25 Million |
|
Kairous Acquisition Corp Ltd
NASDAQ:KACL
|
$10.23 Million |
|
Helios Energy Ltd
AU:HE8
|
$10.23 Million |
|
Arika Resources Ltd
AU:ARI
|
$10.22 Million |
|
Dali Pharmaceutical Co Ltd
SHG:603963
|
$10.22 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in RIV Capital Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 108,847,000 to 217,501,364, a change of 108,654,364 (99.8%).
- Net loss of 80,382,528 reduced equity.
- Share repurchases of 3,986,000 reduced equity.
- Other comprehensive income decreased equity by 54,778,942.
- Other factors increased equity by 247,801,834.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-80.38 Million | -36.96% |
| Share Repurchases | $3.99 Million | -1.83% |
| Other Comprehensive Income | $-54.78 Million | -25.19% |
| Other Changes | $247.80 Million | +113.93% |
| Total Change | $- | 99.82% |
Book Value vs Market Value Analysis
This analysis compares RIV Capital Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | $0.00 | $0.10 | x |
| 2018-12-31 | $2.44 | $0.10 | x |
| 2019-12-31 | $1.11 | $0.10 | x |
| 2020-12-31 | $1.74 | $0.10 | x |
| 2021-12-31 | $1.86 | $0.10 | x |
| 2022-12-31 | $0.66 | $0.10 | x |
| 2023-12-31 | $0.00 | $0.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently RIV Capital Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -36.96%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -1425.74%
- • Asset Turnover: 4.30x
- • Equity Multiplier: 0.01x
- Recent ROE (-36.96%) is above the historical average (-40.62%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | -11.12% | -0.05% | 191.44x | 1.17x | $-51.51K |
| 2018 | 0.96% | 80.50% | 0.01x | 1.03x | $-36.90 Million |
| 2019 | -13.60% | -332.75% | 0.04x | 1.01x | $-49.46 Million |
| 2020 | -42.98% | -1049.79% | 0.04x | 1.08x | $-130.67 Million |
| 2021 | -15.94% | -2959.09% | 0.00x | 1.38x | $-68.69 Million |
| 2022 | -164.69% | -2633.45% | 0.03x | 2.41x | $-190.14 Million |
| 2023 | -36.96% | -1425.74% | 4.30x | 0.01x | $-102.13 Million |
Industry Comparison
This section compares RIV Capital Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| RIV Capital Inc (CNPOF) | $-35.84 Million | -11.12% | N/A | $10.23 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |